Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$0.99 USD
-0.14 (-12.48%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.01 +0.02 (2.12%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-14.10 | 0.00% |
Earnings Summary
For their last quarter, Aptevo Therapeutics (APVO) reported earnings of -$22.03 per share, beating the Zacks Consensus Estimate of $-31.72 per share. This reflects a positive earnings surprise of 30.55%. Look out for APVO's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$14.10 per share, reflecting a year-over-year decrease of 223.14%.
Earnings History
Price & Consensus
Zacks News for APVO
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
APVO: What are Zacks experts saying now?
Zacks Private Portfolio Services